- 首页
- HDAC (Histone deacetylases)
- Remetinostat (SHP-141)
Remetinostat (SHP-141)
Remetinostat (SHP-141) (SHP-141) 是一种基于异羟肟酸的组蛋白脱乙酰酶 (HDAC) 抑制剂，正在开发用于治疗皮肤 T 细胞淋巴瘤。
此产品仅用于科学研究，我们不为任何个人用途提供产品和服务
-
包装价格促销价数量
-
5mg￥1212.00970.00- +
-
10mg￥1850.001480.00- +
-
50mg￥5825.004660.00- +
-
100mg￥9287.007430.00- +
已选
0
种
0
瓶
金额:
￥0.00
首页
收藏
- 货号: ajce50822
- CAS: 946150-57-8
- 别名: SHP-141
- 分子式: C16H21NO6
- 分子量: 323.34
- 纯度: ＞98%
- 溶解度: DMSO : 150 mg/mL (463.91 mM)
- 储存: Store at -20°C
- 库存: 现货
Background
Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1].
[1]. Yijun Deng, et al. Process Development of the Soft Histone Deacetylate Enzyme Inhibitor SHP-141: Acylation of Methyl Paraben and Suberyl Hydroxamic Acid Formation. Org. Process Res. Dev. 2016, 20, 10, 1812-1820.
